Skip to main content

A Colorful Cornucopia of Digestive Tract Pathology

Original release date: 
March 14, 2022
Access to this course expires on:  January 27, 2025 at 11:59 PM Pacific Time
CME 16.25

Course Description
The gastrointestinal tract remains one of the most common sources for surgical pathology specimens. As a result, the difficulties and gray areas in this subspecialty are encountered quite often by pathologists each day. The existence of interobserver variability in many gastrointestinal diagnoses compounds this issue. In contrast, the liver and pancreas give rise to a broad spectrum of uncommon disease entities, making it difficult for pathologists who don’t specialize in these organs to gain diagnostic proficiency. Finally, the WHO recently released the newest edition of their Digestive Tract Tumours blue book which contains key updates and subtle changes that may be unfamiliar to many practicing pathologists.

This course will tackle the professional practice gaps that exist in gastrointestinal pathology, focusing on uncommon findings, obfuscated differential diagnoses, new entities and changes to existing entities.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Understand proper naming and grading of digestive neuroendocrine neoplasms
  • Recognize subtle clues that a microorganism may be contributing to pathologic findings
  • Approach pediatric and adult colitis specimens with the proper mindset, criteria and differentials
  • Evaluate colon polyps and colorectal carcinoma properly to report findings relevant to treatment and prognosis
  • Identify subtle features when evaluating differential diagnoses in medication-induced injury and pancreas neoplasms

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 16.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Raul S. Gonzalez, MD, Amitabh Srivastava, MD, Jeffrey Goldsmith, MD, Maha Guindi, MD, FRCPC, Mari Minu-Kenudson, MD, John Hart, MD, Maria Westerhoff, MD

The following IM Coordinator reported no relevant financial relationships: Scott Owens, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. View and print your certificate by clicking here.

Buy the entire course and get a great discount! Not A Member? Click Here